Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New techniques in gene product analysis.

R A DeLellis, H J Wolfe

Archives of Pathology & Laboratory Medicine

|July 1, 1987

Summary

This summary is machine-generated.

Advances in molecular biology offer powerful new diagnostic tools for clinical medicine. Pathologists can leverage these technologies, including immunohistochemistry and hybridization techniques, for disease research and improved patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CT and PET appearance of a pigmented "black" adrenal adenoma in a patient with lung cancer.

Clinical radiology·2007

Same author

Squamous inclusion cyst with evidence of focal glandular differentiation in an axillary lymph node.

Histopathology·2005

Same author

The neuroendocrine system and its tumors: an overview.

American journal of clinical pathology·2002

Same author

Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Same author

Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.

Human pathology·2001

Same author

Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.

American journal of clinical pathology·2001

Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026

Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026

Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026

Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026

Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026

Same journal

In Reply.

Archives of pathology & laboratory medicine·2026

See all related articles

Area of Science:

Cellular and molecular biology
Genetics
Immunology
Clinical Medicine

Background:

New technologies from biological sciences significantly impact clinical medicine.
Immunohistochemistry allows localization of gene products in tissues.
Blot and in situ hybridization enable characterization of gene expression.

Purpose of the Study:

To highlight the impact of molecular biology advances on clinical medicine.
To emphasize the role of pathologists in utilizing new diagnostic technologies.
To underscore the importance of these technologies for disease research and diagnostics.

Main Methods:

Immunohistochemistry for gene product localization.
Blot hybridization for messenger RNA analysis.

Related Experiment Videos

In situ hybridization for genomic DNA and messenger RNA characterization.

Main Results:

Molecular technologies provide new approaches for understanding disease pathobiology.
These methods offer more objective diagnostic and prognostic criteria for biopsy specimens.
Pathologists are uniquely positioned to lead the implementation of these new methods.

Conclusions:

Pathologists should lead the integration of molecular technologies in disease study.
Pathologists must assess the efficacy of new technologies for clinical problems and research.
These advancements enhance diagnostic and investigative capabilities in pathology.